lanraplenib
Showing 1 - 4 of 4
Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in United States (Lanraplenib,
Recruiting
- Acute Myeloid Leukemia
- +2 more
- Lanraplenib
- Gilteritinib
-
Los Angeles, California
- +3 more
Aug 4, 2022
Lupus Membranous Nephropathy Trial in United States (Filgotinib, Lanraplenib, Filgotinib )
Cutaneous Lupus Erythematosus Trial in Canada, United States (Lanraplenib, Filgotinib, Lanraplenib )
Completed
- Cutaneous Lupus Erythematosus
- Lanraplenib
- +3 more
-
Beverly Hills, California
- +15 more
Jun 1, 2020